Filing Flows › Comparisons › IART vs HAE
Integra Lifesciences Holdings vs Haemonetics: IART and HAE compared
Integra Lifesciences Holdings is the larger company: $411M of revenue in its latest quarter (Q3 2026) against $358M for Haemonetics (Q2 FY27). Haemonetics is growing faster (+9% against +2% a year earlier). Haemonetics is more profitable, with an operating margin of 21.0% against 4.6%.
Where the money goes: IART and HAE
Integra Lifesciences Holdings (IART) · Q3 2026
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Haemonetics (HAE) · Q2 FY27
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
| Integra Lifesciences Holdings (IART) | Haemonetics (HAE) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 FY27 |
| Revenue | $411M | $358M |
| Revenue growth, Y/Y | +2% | +9% |
| Gross margin | — | 61.7% |
| Operating margin | 4.6% | 21.0% |
| Net earnings | $14.9M | $46.3M |
| Net margin | 3.6% | 12.9% |
| Operating cash flow | $96.0M | $128M |
| Free cash flow | $85.7M | $113M |
| Market value | $1.1B | $5.6B |
| P/E | 83.9× | 53.6× |
| Analysts’ mean target | $15.67 | $124.50 |
Where the revenue comes from
Integra Lifesciences Holdings
- Specialty Surgery: $304M (74%)
- Tissue Reconstruction: $107M (26%)
Haemonetics
- Apheresis: $205M (57%)
- MedSurg: $153M (43%)
Questions
Which is bigger, Integra Lifesciences Holdings or Haemonetics?
Integra Lifesciences Holdings is the larger company: $411M of revenue in its latest quarter (Q3 2026) against $358M for Haemonetics (Q2 FY27).
Is Integra Lifesciences Holdings or Haemonetics growing faster?
Haemonetics is growing faster (+9% against +2% a year earlier).
Which is more profitable, Integra Lifesciences Holdings or Haemonetics?
Haemonetics is more profitable, with an operating margin of 21.0% against 4.6%.
More: Integra Lifesciences Holdings earnings · how Integra Lifesciences Holdings makes money · Haemonetics earnings · how Haemonetics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 23, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.